Rapamycin With Grapefruit Juice for Advanced Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2012

Conditions
TumorsNeoplasm Metastasis
Interventions
DRUG

Rapamycin (sirolimus)

Weekly oral doses, dose is assigned at the time of study entry

OTHER

Grapefruit Juice

Daily oral doses starting during the second week on study.

Trial Locations (1)

60637

University of Chicago Hospitals, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT00375245 - Rapamycin With Grapefruit Juice for Advanced Malignancies | Biotech Hunter | Biotech Hunter